Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Pharmacotherapy. 2021 Oct 26;41(11):907–914. doi: 10.1002/phar.2628

Table 2.

Pregnancy outcomes by antidepressant drug

Bupropion
N=406
Citalopram
N=385
Desvenlafaxine
N=16
Duloxetine
N=139
Escitalopram
N=581
Fluoxetine
N=579
Paroxetine
N=55
Sertraline
N=1653
Venlafaxine
N=132
Overall
cohort
N=3694
Pregnancy Outcomes
Neonatal/Fetal Death 3 (0.7%) 2 (0.5%) 0 (0%) 0 (0%) 1 (0.2%) 0 (0%) 0 (0%) 6 (0.3%) 0 (0%) 11 (0.3%)
TTN * 35 (8.6%) 48 (12.5%) 0 (0%) 21 (15.1%) 76 (13.0) 83 (14.3%) 9 (16.4%) 172 (10.4%) 24 (18.2%) 437 (11.8%)
Newborn Intubated 5 (1.2%) 12 (3.1%) 0 (0%) 6 (4.3%) 15 (2.6%) 18 (3.1%) 2 (3.6%) 30 (1.8%) 4 (3.0%) 84 (2.3%)
Pulmonary Hypertension 0 (0%) 2 (0.5%) 0 (0%) 1 (0.7%) 2 (0.3%) 2 (0.4%) 0 (0%) 3 (0.2%) 0 (0%) 10 (0.3%)
Seizures 1 (0.2%) 2 (0.5%) 0 (0%) 0 (0%) 3 (0.5%) 5 (0.9%) 1 (1.8%) 5 (0.3%) 0 (0%) 15 (0.4%)
Jaundice 63 (15.5%) 55 (14.3%) 3 (18.8%) 21 (15.1%) 90 (15.5%) 91 (15.7%) 6 (10.9%) 228 (13.8%) 18 (13.6%) 548 (14.8%)
Cardiac Malformations 13 (3.2%) 19 (4.9%) 0 (0%) 6 (4.3%) 26 (4.5%) 25 (4.3%) 4 (7.3%) 64 (3.9%) 3 (2.3%) 153 (4.1%)
5 Min APGAR <7 50 (12.3%) 56 (14.6%) 3 (18.8%) 22 (15.8%) 66 (11.4%) 99 (17.1%) 9 (16.4%) 213 (12.9%) 20 (15.2%) 504 (13.6%)
Any Adaptation Syndrome * 19 (4.7%) 35 (9.1%) 1 (6.2%) 21 (15.1%) 51 (8.8%) 34 (5.9%) 7 (12.7%) 75 (4.5%) 9 (6.8%) 228 (6.2%)
NICU Admission * 91 (22.4%) 105 (27.3%) 3 (18.8%) 55 (39.6%) 172 (29.6%) 162 (28.0%) 16 (29.1%) 384 (23.2%) 33 (25.0%) 943 (25.5%)
Preterm Birth 61 (15.0%) 56 (14.6%) 2 (12.5%) 32 (23.0%) 85 (14.6%) 100 (17.3%) 8 (14.6%) 238 (14.3%) 18 (13.6%) 559 (15.1%)

Data presented as n (% of with characteristic or outcome) in individual groups.

*

Statistically significant rate differences of outcome distribution between the drugs (p<0.05)

TTN= transient tachypnea of the newborn; NICU = neonatal intensive care unit